Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$4.53 - $8.41 $14,949 - $27,753
-3,300 Reduced 61.74%
2,045 $9,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $17,210 - $63,017
5,345 New
5,345 $39,000
Q2 2022

Aug 09, 2022

BUY
$8.45 - $14.84 $6,759 - $11,872
800 New
800 $11,000
Q1 2022

May 16, 2022

SELL
$11.38 - $21.88 $22,760 - $43,760
-2,000 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$19.66 - $28.11 $39,320 - $56,220
2,000 New
2,000 $42,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.